For further analyses on recent M&A deals see: Following the M&A money, by phase and therapy area, January 29, 2019.
Right click and open in new tab to enlarge.
For more on 2018's venture financing see: Another strong quarter from the venture world, October 01, 2018.
For more on the subject of biggest launches see our article from February: The biggest drug launches – hep C dominates but Tecfidera stands out, February 21, 2018
For more on top-line licensing data see: Pharma content to lease rather than buy, August 29, 2018.
For more on Belviq's recent results see: ESC 2018 – Belviq makes history, but it’s no holy grail... yet, August 28, 2018